Eledon Pharmaceuticals Inc
Eledon Pharmaceuticals Inc (ELDN) Implied Volatility Current
ELDN implied volatility is 50%. IV Rank is 3%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking ELDN implied volatility helps you identify when options premiums on Eledon Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Eledon Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when ELDN IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Eledon Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ELDN, tracking metrics like ELDN IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ELDN signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc.
and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ELDN implied volatility sits today versus where it has been. Our scanner ranks Eledon Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in ELDN IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Eledon Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 17, 2026
Trade options with IV on your side
Track ELDN IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→